Fuse Medical, Inc. Announces Initial Launch of Orbitum™

Fuse Medical, Inc. Announces Initial Launch of Orbitum™ Compression Staple System August 19, 2021 02:25 PM Eastern Daylight Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch and first implantations of the Fuse Orbitum™…

Fuse Medical, Inc. Announces Second Quarter 2021 Financial Results

Fuse Medical, Inc. Announces Second Quarter 2021 Financial Results August 12, 2021 05:00 PM Eastern Daylight Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for…

Fuse Medical, Inc. Announces First Quarter 2021 Financial Results

May 13, 2021 02:06 PM Eastern Daylight Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the quarter ended March 31, 2021 with the Securities…

Fuse Medical, Inc. Announces Launch of FuseChoiceTM Biologics Portfolio

December 22, 2020 03:44 PM Eastern Standard Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch of FuseChoiceTM and FuseChoiceTM Plus Amniotic & Umbilical Membranes, and FuseChoiceTM Plus Amniotic Joint Cushioning Fluid, the latest additions to…

Fuse Medical, Inc. Enters Into Marketing Agreement With CarePICS Telehealth

January 14, 2021 04:33 PM Eastern Standard Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced today an agreement with CarePICS, the latest resource addition to Fuse’s comprehensive portfolio and biologics product offerings for wound care.…

Fuse Medical, Inc. Announces Launch of FuseChoiceTM Biologics Portfolio

December 22, 2020 03:44 PM Eastern Standard Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch of FuseChoiceTM and FuseChoiceTM Plus Amniotic & Umbilical Membranes, and FuseChoiceTM Plus Amniotic Joint Cushioning Fluid, the latest additions to…

FuseChoice Plus – AF

Amniotic Fluid FuseChoice Plus AF Liquid was shown to induce hyaluronic acid production through proliferation of synoviocytes. Proprietary processing method preserves the natural regenerative healing properties of the tissue, the endogenous growth factors, and cytokines responsible for promoting healthy epithelial tissue formation while inhibiting fibrogenesis. E-Beam terminal sterilization provides a sterility assurance level (SAL) of…

FuseChoice Plus AM

Multilayer Amniotic Membrane Multilayer sheet designed to harness the growth factors essential for promoting healing and providing mechanical protection. Proprietary process for maintaining inherent levels of extracellular matrices such as proteins, cytokines, carbohydrates & growth factors. Hydrates rapidly to the surgical site for ease of placement. E-Beam sterilization. Approximately 4X thicker than traditional single layer…

Fuse Medical, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19

November 17, 2020 08:35 PM Eastern Standard Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) announced that it filed its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020 with the Securities and Exchange Commission (“SEC”) on Monday, November 16, 2020. Third Quarter 2020 Highlights Revenue for…